David is the Chief Technology Officer for Cambridge Healthcare Innovations, who develop novel healthcare and medical products to improve people's quality of life. David has been working in the field of respiratory drug delivery for over 25 years, so one of the key focus areas for CHI is the improvement of inhaler devices, which are currently difficult to use and deliver inconsistent performance. He is a practicing physicist, who specialises in aerosol science, fluid dynamics and understanding lung function and its application to good inhaler design. He is a visiting lecturer at Kings College London, joined the organising committee in 2013, and enjoys working with those involved in progressing the science of delivering drugs to the lungs.
